Increasing Doses of Intraoperative Hydromorphone Do Not Reduce Postoperative Pain

Authors

Craig S. Curry, Maine Medical Center
Michael B. Henry, Maine Medical Center
Wendy Craig, Maine Medical CenterFollow
Janelle M. Richard, Maine Medical Center
Denham S. Ward, Maine Medical Center

Document Type

Poster

Publication Date

5-1-2019

Institution/Department

Anesthesiology & Pain Management; Medical Education; Maine Medical Center Research Institute; Center for Outcomes Research and Evaluation

MeSH Headings

Pain, Postoperative

Abstract

Introduction:

• Intermediate and long acting opioids are given intraoperatively to reduce pain during emergence from anesthesia.

• Recent evidence suggests that intraoperative opioids have inconsistent effects on nociception and pain in the immediate postoperative period.

• Multiple potent, short-acting opioids such as remifentanil, sufentanil and fentanyl have been shown to produce dose-related increases in pain scores and opioid consumption in the immediate postoperative recovery period.

• Intraoperative doses of longer acting opioids such as morphine and methadone6 have been shown to reduce pain scores and narcotic requirements in the immediate postoperative period.

• Hydromorphone is an intermediate duration narcotic which is commonly used intraoperatively but has not been studied for its potential to reduce pain in the immediate postoperative period.

Comments

Lambrew Research Retreat

Recommended Citation

Curry, Craig S.; Henry, Michael B.; Craig, Wendy; Richard, Janelle M.; and Ward, Denham S., "Increasing Doses of Intraoperative Hydromorphone Do Not Reduce Postoperative Pain" (2019). MaineHealth Maine Medical Center. 688.
https://knowledgeconnection.mainehealth.org/mmc/688